Literature DB >> 8833914

Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis.

C M Weyand1, A D Wagner, J Björnsson, J J Goronzy.   

Abstract

End organ ischemia, fragmentation of elastic membranes, and aneurysm formation in patients with giant cell vasculitis results from an inflammation destroying the mural layers of large and medium sized arteries. Although the inflammatory infiltrate extends through all layers of the affected blood vessel, the most pronounced changes involve the intima and the internal elastic lamina. Analysis of the functional profile of tissue infiltrating CD68+ cells demonstrates that different subsets of macrophages can be distinguished. TGFbeta1-expressing CD68+ cells coproduce IL-1beta and IL-6, are negative for inducible nitric oxide synthase (iNOS), and exhibit a strong preference for localization in the adventitia. The adventitial homing of TGFbeta1+ CD68+ cells places them in the vicinity of IFN-gamma secreting CD4+ T cells which also accumulate in the exterior layer of the artery. Conversely, iNOS expressing CD68+ cells are negative for TGFbeta and are almost exclusively found in the intimal layer of the inflamed artery. The intimal-medial junction is the preferred site for 72-kD collagenase expressing CD68+ cells. Thus, TGFbeta1-producing macrophages colocalize with activated CD4+ T cells and home to an area of inflammation which is distant from the site of tissue damage but critical in regulating cellular influx, suggesting that TGFbeta1 functions as a proinflammatory mediator in this disease. iNOS- and 72-kD collagenase-producing macrophages accumulate at the center of pathology implying a role of these products in tissue destruction. These data indicate that the microenvironment controls the topographical arrangement as well as the functional commitment of macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833914      PMCID: PMC507598          DOI: 10.1172/JCI118959

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

Review 2.  TGF-beta: regulation of extracellular matrix.

Authors:  A B Roberts; B K McCune; M B Sporn
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

3.  Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.

Authors:  M C Cid; E Campo; G Ercilla; A Palacin; J Vilaseca; J Villalta; M Ingelmo
Journal:  Arthritis Rheum       Date:  1989-07

4.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

6.  Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology.

Authors:  A D Wagner; J Björnsson; G B Bartley; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

Review 7.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

8.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

9.  Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.

Authors:  S M Wahl; J B Allen; G L Costa; H L Wong; J R Dasch
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

10.  Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.

Authors:  J B Allen; C L Manthey; A R Hand; K Ohura; L Ellingsworth; S M Wahl
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  38 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  [Pathogenesis of medium- and large-vessel vasculitis].

Authors:  C M Weyand; J J Goronzy
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

3.  MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.

Authors:  Alicia Rodríguez-Pla; Francisco Martínez-Murillo; Peter J Savino; Ralph C Eagle; Philip Seo; Mark J Soloski
Journal:  Rheumatology (Oxford)       Date:  2009-09-06       Impact factor: 7.580

Review 4.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 5.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

6.  [Giant-cell arteritis: update: diagnosis and therapy].

Authors:  M Schirmer; C Dejaco; W A Schmidt
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

Review 7.  Biologic Therapy for the Treatment of Giant Cell Arteritis.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Rodney Tehrani; Walter Jay
Journal:  Neuroophthalmology       Date:  2014-04-02

8.  Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.

Authors:  A Brack; H L Rittner; B R Younge; C Kaltschmidt; C M Weyand; J J Goronzy
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 9.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

10.  Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.

Authors:  Astrid Borkowski; Brian R Younge; Luke Szweda; Bettina Mock; Johannes Björnsson; Kerstin Moeller; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.